Compare CYD & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYD | AORT |
|---|---|---|
| Founded | 1951 | 1984 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1998 | 1996 |
| Metric | CYD | AORT |
|---|---|---|
| Price | $28.30 | $21.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $59.10 | $42.15 |
| AVG Volume (30 Days) | 122.9K | ★ 520.5K |
| Earning Date | 08-07-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.70% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $13.33 | $11.12 |
| Revenue Next Year | $9.34 | $10.77 |
| P/E Ratio | $32.71 | ★ N/A |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $28.65 | $19.16 |
| 52 Week High | $61.48 | $48.25 |
| Indicator | CYD | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 27.60 | 32.19 |
| Support Level | N/A | $19.49 |
| Resistance Level | $45.94 | $25.04 |
| Average True Range (ATR) | 1.64 | 0.97 |
| MACD | -0.07 | -0.12 |
| Stochastic Oscillator | 2.08 | 1.83 |
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.